TGFB1 and endometriosis: More importantly, disturbances in intracellular signaling pathways related to the pathological expression of EMT mesenchymal biomarkers (TGF-β1, SMAD3 and ILK) may have clinical significance in the diagnostic and therapeutic aspects of endometriosis.